A new bioinformatic pipeline to investigate single cell eQTL analysis is now offered in the sequencing service from Singleron Biotechnologies. Bioinformatic experts at Singleron Biotechnologies, a leader in single cell sequencing, have developed a new single cell eQTL analysis workflow ...
Read More »CD Genomics RNA-Solutions Platform Unveils m7G MeRIP Sequencing for Scientific Research
RNA-Solutions is a platform for revolutionary research in RNA, targeting coding and non-coding RNAs with different physiological functions. Scientists at CD Genomics are ready to help detect various types of RNAs via meticulous and integrative approaches. Recently, the company has ...
Read More »Veracyte’s RNA sequencing-based Afirma Genomic Sequencing Classifier test performs just as well – and on some measures better – in clinical practice
Veracyte today announced that findings demonstrating the strong real-world performance of the Afirma Genomic Sequencing Classifier (GSC) were published in The Journal of Clinical Endocrinology & Metabolism (JCEM). The data, from a meta...
Read More »Pangea Biomed adds $5M in additional funding for its RNA-Seq/AI based multi-cancer response predictor technology
The funding extension, which brings the total seed round to $12M, will advance Pangea’s goal to expand commercial partnerships and US operations Pangea Biomed, the biotech company behind...
Read More »Graphite Bio presents preclinical use of a single-cell RNA sequencing method to assess gene correction outcomes in patients treated with gene-edited therapy
Graphite Bio, a clinical-stage, next-generation gene editing company harnessing the power of high-efficiency precision gene repair to develop therapies with...
Read More »PacBio and Boston Children’s Hospital collaborate to investigate novel variants inaccessible by short-read sequencing
PacBio, a leading developer of high-quality, highly accurate sequencing solutions, today announced its HiFi sequencing technology will be used in a pilot project for the Children’s Rare Disease Cohorts...
Read More »Exai Bio’s RNA sequencing-based liquid biopsy platform delivers promising data on detecting breast cancer at its earliest stages
Researchers at Exai Bio and UCSF have released data demonstrating that Exai’s novel, RNA-based liquid biopsy platform accurately detected breast cancer at the earliest stages and for the smallest tumors. Earlier detection of breast cancer is crucial for optimal patient ...
Read More »Dolomite Bio launches the RNAdia 2.0 reagent kit for single cell research
Dolomite Bio launches the RNAdia 2.0 reagent kit for single cell research, as part of their complete workflow, encompassing everything from sample preparation to bioinformatic analysis. Most researchers will be familiar with the frustrations of sourcing reagents, which wastes precious ...
Read More »Envisagenics Announces Research Collaboration with Bristol Myers Squibb
Collaboration will leverage Envisagenics' SpliceCore® AI platform for accelerated discovery and development of oncology therapeutic candidates...
Read More »Scipio bioscience Announces a Single-Cell Grant Program for Four Researchers to Receive a Complete 3′ scRNA-seq Solution Valued up to US$30,000
With the debut of its novel single-cell solution and its first Grant Program, Scipio bioscience is creating an era where scRNA-seq is versatile, flexible, and accessible for every lab Introduced just six months ago, the Scipio bioscience single-cell RNA-seq solution ...
Read More »